US lawsuit challenges Myriad patents on breast cancer genes
This article was originally published in Scrip
Executive Summary
The American Civil Liberties Union and the Public Patent Foundation have filed suit seeking to invalidate US patents licensed by Myriad Genetics covering the BRCA1 and BRCA2 genes associated with an increased risk of breast and ovarian cancer.